Filter posts

Blurred Lines: Investors Explain Their Re-Thinking of Traditional Private-Only or Public-Only Invest...

The recent expansion and acceleration of the biotech stock market has seen a new willingness …

CFO Magazine: On the IPO On-Ramp

CFO Magazine highlighted the impact of the Jumpstart Our Business Startups (JOBS) Act on smaller …

Biotech Analyst Optimism: Price Targets Post-IPO

In a recent blog post, Bruce Booth of Life Sci VC, writes about the relationship …

Roadblocks and Red Tape Block Search for Cures

Since its passage more than two years ago, the JOBS Act has spurred more than …

Biotech CEOs Speak Out on JOBS Act Success

Enacted in April 2012, the Jumpstart Our Business Startups (JOBS) Act makes the pathway to …

Looking Ahead to the 2014 BIO Investor Forum, Biotech IPO Hopefuls Continue to Seek Funding

As mentioned inĀ Fierce Biotech, a new crop of biotech IPO hopefuls have recently thrown their …

Therapeutic Licensing and M&A Deals

Licensing deals for therapeutic candidates in 2013 dropped to the lowest volume in at least …